Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma Two ...
Durham, N.C.-based Duke Medicine will soon open the $230 million Duke Cancer Center, according to a Chronicle report. The 267,000-square-foot center, part of Duke’s approximately $700 million ...